Caliway Biopharmaceuticals Co Ltd(TW:6919)
NT$68.20-1.90 (-2.71%)
TW:6919
Caliway Biopharmaceuticals Co Ltd earnings date
NT$68.20
At close:-1.90 (-2.71%)
Caliway Biopharmaceuticals Co Ltd (6919) Q2 2022 Earnings Report
TW:6919 Q2 2022 EPS Results
- Actual EPS
- -TWD 0.11
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- ―
TW:6919 Q2 2022 Revenue Results
- Actual Revenue
- TWD 72.00K
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 11/24/2022
- Time
- Before Open
- Conference Call
- Thursday, November 24, 2022
TW:6919 Upcoming Earnings
Caliway Biopharmaceuticals Co Ltd's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
TW:6919 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | ―- | 0.05 | ― | ― |
| Nov 11, 2026 | 2026 (Q3) | ―-0.23 | -0.01 | -4560.00% (-0.23) | |
| Aug 03, 2026 | 2026 (Q2) | ―-0.14 | -0.16 | 10.00% (+0.02) | |
| Apr 10, 2026 | 2026 (Q1) | -0.22-0.07 | -0.11 | 38.60% (+0.04) | |
| Feb 24, 2026 | 2025 (Q4) | -0.170.05 | -0.14 | 138.24% (+0.19) | |
| Nov 07, 2025 | 2025 (Q3) | -0.19-0.01 | -0.09 | 94.44% (+0.09) | |
| Aug 08, 2025 | 2025 (Q2) | -0.13-0.16 | -0.12 | -39.13% (-0.04) | |
| May 05, 2025 | 2025 (Q1) | -0.15-0.11 | -0.16 | 27.39% (+0.04) | |
| Feb 07, 2025 | 2024 (Q4) | -0.13-0.14 | -0.18 | 25.27% (+0.05) | |
| Nov 10, 2024 | 2024 (Q3) | -0.13-0.09 | -0.21 | 57.55% (+0.12) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

